₹ 1,768.35
-23.40 (-1.31%)Open
1790.5High
1800.85Low
1768.35Prev Close
1791.75P/E
44.51Median P/E
31.48P/B
3.68Median P/B
4.77Market Cap
291.27BPEG
0.7Div.Yield
-Bid
-Ask
-Large Cap
291.27B Mkt. Cap.Volatility
-Beta
0.64Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 1,774.11 | 1,775.20 |
10 | 1,739.82 | 1,740.97 |
20 | 1,740.05 | 1,741.13 |
50 | 1,760.61 | 1,761.48 |
100 | 1,849.97 | 1,850.74 |
300 | 1,732.28 | 1,732.76 |
BSE
543245NSE
GLANDISIN
INE068V01023Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.
Srinivasa Sadu
Chief Executive Officer, Managing Director, Whole-Time DirectorRavi Mitra
Chief Financial OfficerSatnam Loomba
Chief Operating OfficerP. Sampath Kumar
Compliance Officer, Company SecretaryAnkit Gupta
Vice President- Strategy and Investments